SCHEMBL14101518

SCHEMBL14101518

c1ccc2c(c1)-c1cccc3c(-c4ccc5sc6ccc(-c7ccc8ccc9cccc%10ccc7c8c9%10)cc6c5c4)ccc-2c13

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
HSD17B10 Q99714 5/20 0.41
TSHR P16473 4/20 0.41
HPGD P15428 4/20 0.41
MAPK1 P28482 3/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
CYP1A2 P05177 2/20 0.41
CASP1 P29466 2/20 0.41
HIF1A Q16665 2/20 0.41
ERBB2 P04626 1/20 0.41
FYN P06241 1/20 0.41
MAOA P21397 1/20 0.41
ACHE P22303 1/20 0.41
AHR P35869 1/20 0.41
ATM Q13315 1/20 0.38
THRB P10828 1/20 0.37
ALOX5 P09917 1/20 0.36
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36
KEAP1 Q14145 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14101523 0.93 CYP1A2 (0.42) ALDH1A1HSD17B10TSHRHPGDL3MBTL1
SCHEMBL14101461 0.93 CYP1A2 (0.45) ALDH1A1HSD17B10TSHRHPGDL3MBTL1
SCHEMBL14101674 0.93 CYP1A2 (0.41) ALDH1A1HSD17B10TSHRHPGDMAPK1
SCHEMBL14101454 0.93 CYP1A2 (0.45) ALDH1A1HSD17B10TSHRHPGDL3MBTL1
SCHEMBL14101442 0.92 CYP1A2 (0.41) ALDH1A1HSD17B10HPGDCYP1A2ERBB2
SCHEMBL14101515 0.92 CYP1A2 (0.45) ALDH1A1HSD17B10TSHRHPGDMAPK1
SCHEMBL14101522 0.92 CYP1A2 (0.44) ALDH1A1HSD17B10TSHRHPGDL3MBTL1
SCHEMBL14101428 0.91 CYP1A2 (0.41) ALDH1A1HSD17B10TSHRHPGDL3MBTL1
SCHEMBL18820492 0.90 ALDH1A1 (0.41) ALDH1A1HSD17B10TSHRHPGDMAPK1
SCHEMBL14101519 0.90 ALDH1A1 (0.38) ALDH1A1HSD17B10TSHRHPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME CYBA, BPNT1, TYR ALDH1A1 70/4885HSD17B10 1075/4885TSHR 4487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.